Person · officer / director

Josh Mailman

Treasurer · Neuroendocrine Tumor Research Foundation

Treasurer at Neuroendocrine Tumor Research Foundation. Listed as an officer, director, or key employee across 1 organization on the Form 990 record.

This is me

Ambiguous identity This name matches 5 other individuals we could not verify as the same person. Each is kept as a separate record below — treat them as distinct people unless an explicit match is confirmed.

Organizations

Roles reported

Others who share this name

Who this is

Profile

Everything on the left is verified from the IRS filings. The biography on the right is compiled from public web sources and grounded to that filed record.

✓ Verified from filings

●

Reported as Treasurer of Neuroendocrine Tumor Research Foundation, based in Quincy, MA.

Facts extracted directly from each organization's Form 990, Part VII.

Biography In progress

We're building a sourced biography for every person — from filings, news, and public records, citing where each fact comes from. Person-name searches are our single largest source of demand, so this is what we're shipping next.

Affiliations

Organizations

Neuroendocrine Tumor Research Foundation Treasurer · $8.7M revenue · Quincy, MATO FUND RESEARCH TO DISCOVER CURES AND MORE EFFECTIVE TREATMENTS FOR NEUROENDOCRINE CANCERS. THE NETRF IS COMMITTED TO IMPROVING THE LIVES OF THOSE…Filed FY2025, FY2024, FY2023, FY2022, FY2021, FY2020 · Source: Form 990, Part VII

Disambiguation

Other people named Josh Mailman

Different individuals who share this name, separated by IRS Schedule R, mailing address, and shared-board evidence. The 990 carries no person identifier, so some may still be the same person.

Josh Mailman 1 organization · Brewster, NYThe Threshold Foundation

Josh Mailman 1 organization · San Leandro, CAPiedmont Yoga Community

Josh Mailman 1 organization · Boulder, COGlobal Greengrants Fund INC

Josh Mailman 1 organization · Omaha, NEThe Education and Research Fdntn for Nuclear Medcn Molecular Imagin

Josh Mailman 1 organization · Oakland, CANorcal Carcinet Support Group

Network

Serves alongside

Other officers, directors & key employees at this person's organizations, by latest reported compensation.

Elyse Gellerman

Chief Executive Officer · FY2025

$213K

Susan Harrington

Chief Development Officer · FY2025

$199K

John Kanki

Director of Research · FY2022

$185K

Susan H Payson

Chief Development Officer · FY2020

$168K

Anna Greene

Director of Research · FY2025

$155K

Christine Coffey

Director of Communications · FY2023

$135K

Jessica Thomas

Director of Patient Education · FY2025

$123K

Christina Coffey Until 072024

Director of Communications · FY2024

$108K

Mark Lewis MD Until 032025

Director · FY2025

Valorie Seyfert as of 492025

Director · FY2025

Julie Shaffer Mebane

Vice President · FY2025

Laurie Rains

Director · FY2025

Network

Recommendations

Written by other verified members of the network — visible once you're a verified person yourself.

Loading…

Explore

Similar organizations

Nonprofits working in the same field — explore who else operates in this space.

University Medical Center Management Corporaton$792.9M revenue · New Orleans, LA

The Against Malaria Foundation$119.4M revenue · Kansas City, MO

Michigan Health Endowment Fund$116.1M revenue · Brighton, MI

Autism Speaks INC$28.8M revenue · Washington, DC

Eagles Autism Challenge INC$14.5M revenue · Philadelphia, PA

Go2 Foundation for Lung Cancer$12.2M revenue · Washington, DC

People like this

Similar leaders

Leaders at organizations in the same field, by reported compensation.

Liliana C Goumnerova MD

Physician · Boston Pediatric Neurosurgical Foundation INC

$4.8M

Nancy Brown

CEO · American Heart Association INC

$4.5M

Richard W Brown

Director/Chair/Pres/CEO · Stowers Resource Management INC

$3.0M

John C Mahler JR

Chief Investment Officer · Cystic Fibrosis Foundation

$2.7M

Jack Mahler MD

Chief Investment Officer · Cystic Fibrosis Foundation

$2.5M

Balagopalan Nair MD

Medical Oncology · Central Arkansas Radiation Therapy

$2.1M